Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 13/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8360529 | 0.93 | PARP1 (0.51) | PARP1NLNHDAC8 | |
| SCHEMBL8359466 | 0.83 | PARP1 (0.66) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL14444082 | 0.81 | NLN (0.64) | PARP1LMNAMAPTBAZ2BNLN | |
| SCHEMBL8359708 | 0.81 | PARP1 (0.60) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8359478 | 0.81 | PARP1 (0.60) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8359603 | 0.78 | PARP1 (0.74) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8359594 | 0.77 | PARP1 (0.63) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8359606 | 0.75 | PARP1 (0.61) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8359607 | 0.75 | PARP1 (0.61) | PARP1LMNAMAPTBAZ2BTAAR1 | |
| SCHEMBL8360522 | 0.75 | HDAC8 (0.57) | PARP1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003014121-A9 | COMPOUNDS, DERIVATIVES, COMPOSITIONS, PREPARATION AND USES | GUILFORD PHARM INC (US) | 2004-03-25 | — | — | WO | disclosed |
| WO-2003014121-A1 | COMPOUNDS, DERIVATIVES, COMPOSITIONS, PREPARATION AND USES | GUILFORD PHARMACEUTICALS INC. (US) | 2003-02-20 | — | — | WO | disclosed |